Syövänhoidon vastuualue

Julkaisut 2011
Publications 2011

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.

1 Agborsangaya CB et al. Association between Epstein-Barr virus infection and risk for development of pregnancy-associated breast cancer: joint effect with vitamin D?
2 Barok M et al. Trastuzumab-DM1 is highly effective in preclinical models of HER2-positive gastric cancer.
3 Barok M et al. Trastuzumab-DM1 causes tumour growth inhibition by mitotic catastrophe in trastuzumab-resistant breast cancer cells in vivo.
4 Hautamäki-Lamminen K et al. Syöpäpotilaat ja seksuaalisuuteen liittyvät tiedontarpeet.
5 Joensuu H et al. Very high quantitative tumor HER2 content and outcome in early breast cancer.
6 Junttila TT et al. Vasta-aineisiin konjugoidut solunsalpaajat tulossa syövän hoitoon.
7 Kellokumpu-Lehtinen P et al. Anaemia: a rare but neglected problem among Finnish patients receiving chemotherapy for solid tumours.
8 Konsti J et al. Development and evaluation of a virtual microscopy application for automated assessment of Ki-67 expression in breast cancer.
9 Koskinen MJ et al. Intraepidermal nerve fibre density in cancer patients receiving adjuvant chemotherapy.
10 Lehtimäki T et al. Long-term prognosis of breast cancer detected by mammography screening or other methods.
11 Lehto US et al. Impact of life on survival of patient with localized melanoma.
12 Peltoniemi P et al. The effect of hospital volume on the outcome of breast cancer surgery.
13 Pelttari LM et al. RAD51C is a susceptibility gene for ovarian cancer.
14 Penttinen HM et al. Quality of life and physical performance and activity of breast cancer patients after adjuvant treatments.
15 Rappu P et al. Detection of melanoma-derived cancer-testis antigen CT16 in patient sera by a novel immunoassay.
16 Rossi M et al. PET imaging in a longitudinal non-Hodgkin's lymphoma study: association with tumor volume.
17 Salonen P et al. Changes in quality of life in patients with breast cancer.
18 Salonen P et al. Individual face-to-face support and quality of life in patients with breast cancer.
19 Sihto H et al. Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort study.
20 Smith IE et al. First-line bevacizumab plus taxane-based chemotherapy for locally recurrent or metastatic breast cancer: safety and efficacy in an open-label study in 2,251 patients.
21 Soimakallio S et al. Clinical audit: Development of the criteria of good practices.
22 Vihinen PP et al. Circulating levels of VEGFR-1 and VEGFR-2 in patients with metastatic melanoma treated with chemoimmunotherapy alone or combined with bevacizumab.
23 Wahlin BE et al. T Cells in Tumors and Blood Predict Outcome in Follicular Lymphoma Treated with Rituximab.
24 Wu X et al. Early Treatment Response Evaluation in Patients with Diffuse Large B-Cell Lymphoma-A Pilot Study Comparing Volumetric MRI and PET/CT.
25 Wu X et al. Diffusion-weighted MRI in early chemotherapy response evaluation of patients with diffuse large B-cell lymphoma - a pilot study: comparison with 2-deoxy-2-fluoro- D-glucose-positron emission tomography/computed tomography.
26 Wu X et al. No correlation between glucose metabolism and apparent diffusion coefficient in diffuse large B-cell lymphoma: A PET/CT and DW-MRI study.

Julkaisutietokanta 21.9.2012 Publications Data Base 21.9.2012